QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$41.67 USD
-0.91 (-2.14%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $41.66 -0.01 (-0.02%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth C Momentum B VGM
Brokerage Reports
0 items in cart
QuidelOrtho Corporation [QDEL]
Reports for Purchase
Showing records 141 - 160 ( 186 total )
Company: QuidelOrtho Corporation
Industry: Medical - Products
1Q12 Recap - a Tad Soft on Revs and EPS - No Major Red Flags - Pipeline Appears on Track - Still Not Feeling the Risk/Reward - Reaffirm NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
1Q12 Financial Preview - Expectations Relatively Low - Disconnect Between Shares & Financials Persists - Its All About Pipeline - Maintaining NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Handheld C.Dfficile Test Launched in EU - Timing Inline with Expectations - Zero Performance, Workflow & Pricing Info
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Week 10 Flu Update - US Activity Up Slightly Wk/Wk - EU Activity Softer
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
US Activity Up More Strongly.Wk/Wk But 1Q12 Still Likely to Be Soft - Maintaining NEUTRAL.
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Week 8 Flu Update - US Activity Continues Increase Off Small Base - EU Activity Pauses - Reaffirming NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
4Q11 Results Mixed - Better Top-line & EPS Offset by Cautious 1Q12 Tone & Higher Opex Guidance - Pipeline Ok - FCF Better - Reaffirming NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Company: QuidelOrtho Corporation
Industry: Medical - Products
Week 6 Flu Update - US Activity Increasing Off Low Levels
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Week 5 Flu Update- US Activity Increases But Still Unusually Light- EU Activity Gradually Rising as Well- Reaffirming NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Week 3 Flu Update - Activity Up Slightly in US Yet Still Near Ten-Year YTD Lows - Maintaining NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Week 1 Flu Update: Activity Remains Lighter Than Normal, Season-to-Date Levels Lowest Since 2003 -Maintaining NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Maintaining NEUTRAL - Flu and Product Update - Flu Activity Up Slightly in Week 50
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Maintaining NEUTRAL - BD''s Veritor Approval Spells Low-Cost, Low-End Competition for Sofia
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
3Q11 Results Top Estimates Due to Timing of Flu & Low Inventories
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Company: QuidelOrtho Corporation
Industry: Medical - Products
Reaffirming NEUTRAL Rating Following Uneventful 2Q11 Results - Slightly More Encouraged by Pipeline Progress - Wait To Buy It at Lower Price
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z